The short version

From the latest prices and each company's SEC filings. Who's ahead on each measure, not which to buy.

  • Accelerant Holdings is the larger company, worth $5.3B, about 1.4 times CorVel.
  • Accelerant Holdings grew revenue faster over the last year (+62.9% vs +10.7%).
  • CorVel's price assumes faster free cash flow growth: about 12% a year, against -0% for Accelerant Holdings (reverse DCF).

Side by side

The stronger figure is shaded where higher (or, for valuation multiples, lower) reads as better. How the implied growth works.

MeasureARXCRVL
Market cap$5.3B$3.9B
Share price$19.80$77.16
Revenue (last fiscal year)$913M$959M
Free cash flow (last fiscal year)$404M$110M
Revenue growth, last year+62.9%+10.7%
Revenue growth per year, last 5 fiscal years+62.9%+10.4%
Operating margin-110.8%—
Net margin-119.3%11.7%
Return on equity-190.5%28.2%
P/E (trailing)—37.2x
Price / free cash flow13.2x42.4x
EV / EBITDA—20.3x
FCF growth the price implies-0.48%12.4%
Dividend yield——
Debt / equity11.4x0.69x
Fundamental gradeDC
Superinvestors holding it12
Insider purchases, last 12 months40

Results from SEC filings

Revenue and free cash flow by fiscal year, from each company's 10-K filings.

Accelerant Holdings

YearRevenueFree cash flowOp. margin
2023$344M$257M-12.8%
2024$603M$751M5.3%
2025$913M$404M-144.8%

CorVel

YearRevenueFree cash flowOp. margin
2022$646M$37M—
2023$719M$56M—
2024$795M$70M—
2025$896M$92M—
2026$959M$110M—

Where the revenue comes from

Accelerant Holdings · by segments, 2025

Underwriting$431M42%
Exchange Services$335M33%
MGA Operations$249M25%

CorVel · by products, 2026

Patient Management Services$597M62%
Network Solutions Services$362M38%
Compare them in fullFifteen years of statements, quarterly results, DCF and IRR models, and any number of peers side by side.
Open ARX in Investingly

Questions

Which is bigger, Accelerant Holdings or CorVel?

Accelerant Holdings (ARX), at $5.3B against $3.9B.

Which grows faster, ARX or CRVL?

Accelerant Holdings: revenue grew +62.9% over the last year, against +10.7%.

Prices and ratios as of the last daily update; statements from SEC filings. Information only, not investment advice.